CDEK
← All drugs Report issue

wharton's jelly mesenchymal stem cells

Cell therapyexperimental

Clinical trial activity

45 trials · 61 clinical orgs · 0 marketing orgs

Phase 1
28
Phase 2
31
Phase 3
6
Phase 4
0

Earliest trial started Mar 1, 2015 (NCT02368587)

Timeline

2010s

  1. Jan 1, 2015

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2016

    Earliest Phase 1 Sponsor(trial)

  3. Jan 1, 2019

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

  • Stem CellTissue restoration

    Stem Cell tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • wharton' jelly-derived mesenchymal stem cells
  • wharton's jelly mesenchymal stem cells

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07018739Phase 1/Phase 2 (Phase 2)Jun 30, 2026Mahidol University, Siriraj Hospital
NCT06981338Phase 1/Phase 2 (Phase 2)Sep 1, 2025Institut Guttmann
NCT06608134Early Phase 1 (Phase 1)Oct 1, 2024R3 Medical Research
NCT06495437N/AAug 1, 2024—
NCT06304025Phase 1/Phase 2 (Phase 2)Jun 30, 2024Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle, Instituto Distrital de Ciencia Biotecnología e Innovacion en Salud
NCT06218134N/AMar 30, 2024Sungkyunkwan University
NCT06361485Phase 1Mar 25, 2024R3 Medical Research, R3 Stem Cell
NCT05855707Phase 1Sep 30, 2023University of Lorraine, University of Paris
NCT05413148Phase 2/Phase 3 (Phase 3)Aug 5, 2022Erciyes University
NCT06293950Phase 1Mar 9, 2022University of Jordan
NCT04711304Phase 1/Phase 2 (Phase 2)Jan 1, 2022BioIntegrate, El-Amin Orthopaedic & Sports Medicine Institute
NCT04719793Early Phase 1 (Phase 1)Jan 1, 2022BioIntegrate, El-Amin Orthopaedic & Sports Medicine Institute
NCT05054803Phase 1/Phase 2 (Phase 2)Oct 31, 2021Academic Research Organization (ARO) - VHIR, Banc de Sang i Teixits, Institut Guttmann
NCT04869397Phase 2Jun 14, 2021McGill University
NCT04896853Phase 1May 18, 2021Karolinska Institute, NextCell Pharma, Orebro University
NCT05043610Phase 3Jan 1, 2021Cell Tech Pharmed Company, Iran, Government of Iran, Shiraz University
NCT04651855Phase 1/Phase 2 (Phase 2)Dec 2, 2020Government of Poland, Polski Bank Komorek Macierzystych JSC (PBKM)
NCT04551456Phase 2Nov 30, 2020Chinese Academy of Medical Sciences, Government of China, Peking University, People's Liberation Army of China, Xijing Hospital
NCT04625738Phase 2Nov 6, 2020University of Lorraine
NCT04551443Phase 2Nov 1, 2020Chinese Academy of Medical Sciences, Government of China, Peking University, People's Liberation Army of China, Xijing Hospital
Showing 20 of 45 trials
Page 1 / 3

Organizations

Research & Development (61)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
University of JordanAcademic/Hospital4222017
Ankara Universitesi TeknokentAcademic/Hospital3312019
Banc de Sang i TeixitsAcademic/Hospital3312016
BioIntegrateFor profit3322020
Government of ChinaGovernment3312015
Institut GuttmannAcademic/Hospital3112016
NextCell PharmaFor profit3322017
People's Liberation Army of ChinaGovernment3012015
Al-Ahliyya Amman UniversityAcademic/Hospital2212017
Chinese Academy of Medical SciencesAcademic/Hospital2012020
El-Amin Orthopaedic & Sports Medicine InstituteAcademic/Hospital2022022
Erciyes UniversityAcademic/Hospital2222019
Government of PolandGovernment2022017
Peking UniversityAcademic/Hospital2012020
R3 Medical ResearchFor profit2112024
University of LorraineAcademic/Hospital2222020
Xijing HospitalAcademic/Hospital2012020
Academic Research Organization (ARO) - VHIRAcademic/Hospital1012021
An-Najah National UniversityAcademic/Hospital1012019
APHP - Hôpital NeckerAcademic/Hospital1012020
61 organizations
Page 1 / 4